First REal-Life Evaluation of Darifenacin in Overactive Bladder Patients During 3 Months.

Trial Profile

First REal-Life Evaluation of Darifenacin in Overactive Bladder Patients During 3 Months.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Darifenacin (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Acronyms FREEDOM
  • Sponsors Bayer
  • Most Recent Events

    • 20 Dec 2011 Actual end date changed from Oct 2008 to Feb 2009 as reported by ClinicalTrials.gov.
    • 19 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top